Cargando…
Reversal of Tau-Dependent Cognitive Decay by Blocking Adenosine A1 Receptors: Comparison of Transgenic Mouse Models with Different Levels of Tauopathy
The accumulation of tau is a hallmark of several neurodegenerative diseases and is associated with neuronal hypoactivity and presynaptic dysfunction. Oral administration of the adenosine A(1) receptor antagonist rolofylline (KW-3902) has previously been shown to reverse spatial memory deficits and t...
Autores principales: | Anglada-Huguet, Marta, Endepols, Heike, Sydow, Astrid, Hilgers, Ronja, Neumaier, Bernd, Drzezga, Alexander, Kaniyappan, Senthilvelrajan, Mandelkow, Eckhard, Mandelkow, Eva-Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252552/ https://www.ncbi.nlm.nih.gov/pubmed/37298211 http://dx.doi.org/10.3390/ijms24119260 |
Ejemplares similares
-
Assessment of the In Vivo Relationship Between Cerebral Hypometabolism, Tau Deposition, TSPO Expression, and Synaptic Density in a Tauopathy Mouse Model: a Multi-tracer PET Study
por: Endepols, Heike, et al.
Publicado: (2022) -
Spreading of Tau Protein Does Not Depend on Aggregation Propensity
por: Rodrigues, Sara, et al.
Publicado: (2023) -
Suppressing Tau Aggregation and Toxicity by an Anti-Aggregant Tau Fragment
por: Pir, Ghulam Jeelani, et al.
Publicado: (2018) -
Functional networks are impaired by elevated tau-protein but reversible in a regulatable Alzheimer’s disease mouse model
por: Green, Claudia, et al.
Publicado: (2019) -
A combinatorial native MS and LC-MS/MS approach reveals high intrinsic phosphorylation of human Tau but minimal levels of other key modifications
por: Drepper, Friedel, et al.
Publicado: (2021)